BMC Microbiology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: April 5, 2024
Abstract
Obesity
is
a
metabolic
disorder
closely
associated
with
profound
alterations
in
gut
microbial
composition.
However,
the
dynamics
of
species
composition
and
functional
changes
microbiome
obesity
remain
to
be
comprehensively
investigated.
In
this
study,
we
conducted
meta-analysis
metagenomic
sequencing
data
from
both
obese
non-obese
individuals
across
multiple
cohorts,
totaling
1351
fecal
metagenomes.
Our
results
demonstrate
significant
decrease
richness
diversity
bacteriome
virome
patients.
We
identified
38
bacterial
including
Eubacterium
sp.
CAG:274,
Ruminococcus
gnavus
,
eligens
Akkermansia
muciniphila,
1
archaeal
species,
Methanobrevibacter
smithii
that
were
significantly
altered
obesity.
Additionally,
observed
abundance
five
viral
families:
Mesyanzhinovviridae
Chaseviridae
Salasmaviridae
Drexlerviridae
Casjensviridae
.
Functional
analysis
indicated
distinct
signatures
as
primary
driver
for
function
enrichment
obesity,
muciniphila
bicirculans
siraeum
drivers
healthy
control
group.
our
suggest
antibiotic
resistance
genes
virulence
factors
may
influence
development
Finally,
demonstrated
vOTUs
achieved
diagnostic
accuracy
an
optimal
area
under
curve
0.766
distinguishing
controls.
findings
offer
comprehensive
generalizable
insights
into
features
potential
guide
microbiome-based
diagnostics.
Gut Microbes,
Journal Year:
2021,
Volume and Issue:
13(1)
Published: Jan. 1, 2021
Blautia
is
a
genus
of
anaerobic
bacteria
with
probiotic
characteristics
that
occur
widely
in
the
feces
and
intestines
mammals.
Based
on
phenotypic
phylogenetic
analyses,
some
species
genera
Clostridium
Ruminococcus
have
been
reclassified
as
Blautia,
so
to
date,
there
are
20
new
valid
published
names
this
genus.
An
extensive
body
research
has
recently
focused
effects
genus,
such
biological
transformation
its
ability
regulate
host
health
alleviate
metabolic
syndrome.
This
article
reviews
origin
factors
affect
abundance
discusses
role
health,
thus
laying
theoretical
foundation
for
development
functional
microorganisms
properties.
Gut,
Journal Year:
2022,
Volume and Issue:
71(3), P. 544 - 552
Published: Jan. 26, 2022
Background
Long-term
complications
after
COVID-19
are
common,
but
the
potential
cause
for
persistent
symptoms
viral
clearance
remains
unclear.
Objective
To
investigate
whether
gut
microbiome
composition
is
linked
to
post-acute
syndrome
(PACS),
defined
as
at
least
one
symptom
4
weeks
of
SARS-CoV-2
virus.
Methods
We
conducted
a
prospective
study
106
patients
with
spectrum
severity
followed
up
from
admission
6
months
and
68
non-COVID-19
controls.
analysed
serial
faecal
258
samples
using
shotgun
metagenomic
sequencing,
correlated
results
months.
Results
At
months,
76%
had
PACS
most
common
were
fatigue,
poor
memory
hair
loss.
Gut
microbiota
was
associated
occurrence
PACS.
Patients
without
showed
recovered
profile
comparable
that
characterised
by
higher
levels
Ruminococcus
gnavus
,
Bacteroides
vulgatus
lower
Faecalibacterium
prausnitzii
.
Persistent
respiratory
opportunistic
pathogens,
neuropsychiatric
fatigue
nosocomial
including
Clostridium
innocuum
Actinomyces
naeslundii
(all
p<0.05).
Butyrate-producing
bacteria,
Bifidobacterium
pseudocatenulatum
largest
inverse
correlations
Conclusion
These
findings
provided
observational
evidence
compositional
alterations
in
long-term
COVID-19.
Further
studies
should
modulation
can
facilitate
timely
recovery
syndrome.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Aug. 18, 2022
Abstract
The
gut
microbiome
is
an
important
determinant
in
various
diseases.
Here
we
perform
a
cross-sectional
study
of
Japanese
adults
and
identify
the
Blautia
genus,
especially
B.
wexlerae
,
as
commensal
bacterium
that
inversely
correlated
with
obesity
type
2
diabetes
mellitus.
Oral
administration
to
mice
induce
metabolic
changes
anti-inflammatory
effects
decrease
both
high-fat
diet–induced
diabetes.
beneficial
are
unique
amino-acid
metabolism
produce
S-adenosylmethionine,
acetylcholine,
l
-ornithine
carbohydrate
resulting
accumulation
amylopectin
production
succinate,
lactate,
acetate,
simultaneous
modification
bacterial
composition.
These
findings
reveal
regulatory
pathways
host
microbial
may
provide
novel
strategies
preventive
therapeutic
approaches
for
disorders.
Annals of Neurology,
Journal Year:
2021,
Volume and Issue:
89(6), P. 1195 - 1211
Published: April 20, 2021
Objective
This
study
was
undertaken
to
investigate
the
gut
microbiome
in
progressive
multiple
sclerosis
(MS)
and
how
it
relates
clinical
disease.
Methods
We
sequenced
microbiota
from
healthy
controls
relapsing–remitting
MS
(RRMS)
patients
correlated
levels
of
bacteria
with
features
disease,
including
Expanded
Disability
Status
Scale
(EDSS),
quality
life,
brain
magnetic
resonance
imaging
lesions/atrophy.
colonized
mice
MS‐derived
Akkermansia
induced
experimental
autoimmune
encephalomyelitis
(EAE).
Results
Microbiota
β‐diversity
differed
between
but
did
not
differ
RRMS
or
based
on
disease‐modifying
therapies.
Disease
status
had
greatest
effect
β‐diversity,
followed
by
body
mass
index,
race,
sex.
In
both
RRMS,
we
found
increased
Clostridium
bolteae
,
Ruthenibacterium
lactatiformans
decreased
Blautia
wexlerae
Dorea
formicigenerans
Erysipelotrichaceae
CCMM
.
Unique
MS,
elevated
Enterobacteriaceae
g24
FCEY
Agathobaculum
Several
species
were
associated
higher
EDSS
fatigue
scores.
Contrary
view
that
has
a
detrimental
role,
linked
lower
disability,
suggesting
beneficial
role.
Consistent
this,
isolated
ameliorated
EAE,
which
reduction
RORγt+
IL‐17–producing
γδ
T
cells.
Interpretation
Whereas
some
alterations
are
shared
relapsing
identified
unique
measures
Furthermore,
may
be
compensatory
response
microbiome.
ANN
NEUROL
2021;89:1195–1211
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2021,
Volume and Issue:
11
Published: Dec. 23, 2021
The
mammalian
gut
microbial
community,
known
as
the
microbiota,
comprises
trillions
of
bacteria,
which
co-evolved
with
host
and
has
an
important
role
in
a
variety
functions
that
include
nutrient
acquisition,
metabolism,
immunity
development,
more
importantly,
it
plays
critical
protection
from
enteric
infections
associated
exogenous
pathogens
or
indigenous
pathobiont
outgrowth
may
result
healthy
community
disruption.
Microbiota
evolves
complex
mechanisms
to
restrain
pathogen
growth,
included
competition,
competitive
metabolic
interactions,
niche
exclusion,
induction
immune
response,
are
collectively
termed
colonization
resistance.
On
other
hand,
have
also
developed
counterstrategies
expand
their
population
enhance
virulence
cope
microbiota
resistance
cause
infection.
This
review
summarizes
available
literature
on
relationship
occurring
between
intestinal
pathogens,
describing
how
can
mediate
against
bacterial
enteropathogens
overcome
this
well
understanding
interaction
inform
future
therapies
infectious
diseases.
Abstract
The
human
gastrointestinal
(GI)
tract
harbors
diverse
microbes,
and
the
family
Lachnospiraceae
is
one
of
most
abundant
widely
occurring
bacterial
groups
in
GI
tract.
Beneficial
adverse
effects
on
host
health
were
reported,
but
diversities
at
species/strain
levels
as
well
their
metabolites
have
been,
so
far,
not
documented.
In
present
study,
we
report
collection
77
h
uman‐originated
L
a
ch
nospiraceae
sp
ecies
(please
refer
hLchsp,
https://hgmb.nmdc.cn/subject/lachnospiraceae
)
vitro
metabolite
profiles
110
strains
(
https://hgmb.nmdc.cn/subject/lachnospiraceae/metabolites
).
hLchsp
produced
242
17
categories.
larger
categories
alcohols
(89),
ketones
(35),
pyrazines
(29),
short
(C2–C5),
long
(C
>
5)
chain
acids
(31),
phenols
(14),
aldehydes
other
30
compounds.
Among
them,
22
aromatic
well‐known
beneficial
gut
microbial
metabolite,
butyric
acid,
was
generally
by
many
strains,
Agathobacter
rectalis
strain
Lach‐101
Coprococcus
comes
NSJ‐173
top
2
acid
producers,
331.5
310.9
mg/L
vitro,
respectively.
Further
analysis
publicly
available
cohort‐based
volatile‐metabolomic
data
sets
feces
revealed
that
over
30%
prevailing
volatile
covered
identified
this
study.
This
study
provides
resources
together
with
metabolic
for
future
studies
host–microbe
interactions
developments
novel
probiotics
or
biotherapies.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Jan. 16, 2023
Abstract
The
interplay
between
western
diet
and
gut
microbiota
drives
the
development
of
non-alcoholic
fatty
liver
disease
its
progression
to
steatohepatitis.
However,
specific
microbial
metabolic
mediators
contributing
steatohepatitis
remain
be
identified.
Here,
a
choline-low
high-fat
high-sugar
diet,
representing
typical
named
CL-HFS,
successfully
induces
male
mouse
with
some
features
human
disease,
such
as
hepatic
inflammation,
steatosis,
fibrosis.
Metataxonomic
metabolomic
studies
identify
Blautia
producta
2-oleoylglycerol
clinically
relevant
bacterial
CL-HFS-induced
In
vivo
validate
that
both
promote
inflammation
fibrosis
in
normal
diet-
or
CL-HFS-fed
mice.
Cellular
molecular
reveal
GPR119/TAK1/NF-κB/TGF-β1
signaling
pathway
mediates
2-oleoylglycerol-induced
macrophage
priming
subsequent
stellate
cell
activation.
These
findings
advance
our
understanding
pathogenesis
provide
targets
for
developing
microbiome/metabolite-based
therapeutic
strategies
against
Cell Host & Microbe,
Journal Year:
2024,
Volume and Issue:
32(6), P. 996 - 1010.e4
Published: June 1, 2024
The
composition
and
maturation
of
the
early-life
microbiota
are
modulated
by
a
number
perinatal
factors,
whose
interplay
in
relation
to
microbial
vertical
transmission
remains
inadequately
elucidated.
Using
recent
strain-tracking
methodologies,
we
analyzed
mother-to-infant
two
different
birth
environments:
hospital-born
(vaginal/cesarean)
home-born
(vaginal)
infants
their
mothers.
While
delivery
mode
primarily
explains
initial
compositional
differences,
place
impacts
timing-being
early
homebirths
delayed
cesarean
deliveries.
Transmission
patterns
vary
greatly
across
species
groups,
yet
certain
species,
like
Bifidobacterium
longum,
consistently
vertically
transmitted
regardless
setting.
Strain-level
analysis
B.
longum
highlights
relevant
consistent
subspecies
replacement
mainly
explained
breastfeeding
practices,
which
drive
changes
human
milk
oligosaccharide
(HMO)
degrading
capabilities.
Our
findings
highlight
how
setting,
duration,
other
lifestyle
preferences
collectively
shape
transmission,
impacting
infant
gut
colonization
during
life.